Streptomyces sp producing tautomycetin and immunosuppressant comprising tautomycetin as active ingredient

1. Field of the Invention The present invention relates to Streptomyces sp. producing tautomycetin which possesses an immunosuppressive or antibacterial activities, a process for preparing tautomycetin from the said microorganism, and an immunosuppressant or immunosuppressive pharmaceutical composit...

Full description

Saved in:
Bibliographic Details
Main Authors Chun, Hyoung Sik, Kim, Jong Gwan, Chang, Hung Bae, Moon, Seung Kee, Son, Hyeog Jin, Hong, Chung Il, Kim, Jung Woo, Lyu, Nam Hyun
Format Patent
LanguageEnglish
Published 19.08.2003
Online AccessGet full text

Cover

Loading…
More Information
Summary:1. Field of the Invention The present invention relates to Streptomyces sp. producing tautomycetin which possesses an immunosuppressive or antibacterial activities, a process for preparing tautomycetin from the said microorganism, and an immunosuppressant or immunosuppressive pharmaceutical composition comprising tautomycetin as an active ingredient which suppresses interleukin-2 production, CD69 and interleukin-2 receptor(IL-2R) expression on the cell surface, and graft rejection in the organ transplantation. The present inventors isolated a soil microorganism which produces a substance possessing antibiotic and immunosuppressive activities, and identified the said microorganism and substance as a novel Streptomyces sp. and tautomycetin, respectively. Further, the present inventors developed a method of manufacturing the tautomycetin in a large scale from the culture of the said microorganism and discovered that tautomycetin suppresses mouse mixed lymphocyte reaction(MLR) and the expression of IL-2 based on a series of experiments employing cell line transfected with a recombinant gene.